Miromatrix Medical Inc reports results for the quarter ended in September - Earnings Summary

Miromatrix Medical

14/11/2022 22:02

* Miromatrix Medical Inc  MIRO.OQ  reported a quarterly
adjusted
loss of 37 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue rose 20% to $12.00 thousand from a year ago;
analysts
expected $3.50 thousand. 
    * Miromatrix Medical Inc's reported EPS for the quarter was
a loss
of 37 cents​.
    * The mean earnings estimate of analysts had risen by
about 18.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Miromatrix Medical Inc shares had fallen by 0.7% this
quarter and lost 7.2% so far this year.
    * The company reported a quarterly loss of $7.63 million.
    * Wall Street's median 12-month price target for Miromatrix
Medical Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.37          Beat
 Jun. 30 2022      -0.33          -0.40          Missed
 Mar. 31 2022      -0.29          -0.35          Missed
 Dec. 31 2021      -0.15          -0.27          Missed